Tissue of Origin: Rectal Tumor
Cancer Type: Melanoma
SK-MEL-23 is a human melanoma cell line.
This cell line was established from a metastatic lymph node in a person with malignant melanoma.
- Lloyd J. Old, MD, former William E. Snee Chair in Cancer Immunology, MSK; former Director of the Ludwig Institute for Cancer Research
PubMed=978138; DOI=10.1084/jem.144.4.873 Shiku H., Takahashi T., Oettgen H.F., Old L.J.Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.J. Exp. Med. 144:873-881(1976)
This cell line may be licensed nonexclusively for research or commercial purposes.
For internal research purposes by a commercial entity: Utilize MSK’s Express License, attached here. In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. Please note: This license is only available for select cell lines, including this one.
To proceed, please download this contract, fill in all relevant fields, and email a scanned version to [email protected]. Once this license has been executed by MSK, you will receive a signed copy and invoice, and can then place your order with ATCC.
For licensing requests for a commercial purpose: Contact MSK’s Tangible Materials team at [email protected].